News

Allurion outlines path to FDA submission and expects revenue ramp as B2B2C strategy expands in 2025
Q1 2025 Management View Shantanu Gaur, CEO, stated the company "delivered the first quarter in line with expectations, ...
STAT4h
Former FDA head Robert Califf says RFK Jr.’s vaccine rhetoric is ‘doing harm’ to Americans
Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the ...
pharmaphorum6h
AI-powered drug discovery is outpacing regulators, with Eric Luellen
During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences. Luellen shared the company's ambitious mission ...
STAT8h
A big struggle over how to implement AI
The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...
DATAQUEST18h
AI in healthcare is the pursuit of insights, not perfection: CitiusTech
CitiusTech's John Edward discusses how AI can transform healthcare despite imperfect data, exploring Agentic AI, data quality ...